Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Q-QIV (GSK2282512A)
print preview
bookmark
share with colleague
General Information
Company
GlaxoSmithKline plc
Description
Intramuscular quadrivalent influenza vaccine containing 2 strains of type A (H1N1 and H3N2) and 2 strains of type B (1 each from Yamagata and Victoria lineages)
Molecular Target
Mechanism of Action
Latest Stage of Development
Registration
Indication
Influenza virus
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy